GMRE
Global Medical REIT Inc.
NYSE · Real Estate · REIT - Healthcare Facilities · US
$35.74
−1.24%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 148.2M | 148.2M | 138.4M | 140.9M | 137.2M |
| Cost of Revenue | 39.0M | — | 29.3M | 28.1M | 25.2M |
| Gross Profit | 74.0M | — | 109.2M | 112.9M | 112.0M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 20.0M | 20.0M | 21.1M | 16.9M | 16.5M |
| General & Admin Expense | 20.0M | 20.0M | 21.1M | 16.9M | 16.5M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 62.0M | 128.2M | 55.4M | 58.1M | 56.7M |
| Total Operating Expenses | 82.0M | 148.2M | 76.5M | 75.0M | 73.3M |
| Cost and Expenses | 121.0M | 148.2M | 105.7M | 103.1M | 98.5M |
| Operating Income (EBIT) | 30.4M | — | 32.7M | 37.9M | 38.7M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 35.1M | 31.8M | 28.7M | 30.9M | 25.2M |
| Net Interest Income | (35.1M) | (31.8M) | (28.7M) | (30.9M) | (25.2M) |
| Other Non-Op Income/Expense | (31.1M) | — | (26.0M) | (16.1M) | (18.7M) |
| Non-Operating Income (excl Interest) | 15.0M | (19.6M) | (2.7M) | (14.8M) | (6.5M) |
| EBT (Pre-Tax Income) | (8.2M) | (12.1M) | 6.7M | 21.7M | 20.0M |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (12.1M) | (12.1M) | 6.6M | 20.6M | 19.1M |
| Earnings from Cont. Ops | (12.1M) | (12.1M) | 6.7M | 21.7M | 20.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (12.1M) | (12.1M) | 811.0K | 14.8M | 13.3M |
| Per Share | |||||
| Basic EPS | ($0.51) | ($0.91) | $0.31 | $5.75 | $1.02 |
| Diluted EPS | ($0.51) | ($0.91) | $0.31 | $5.75 | $1.02 |
| Revenue Per Share | $11.08 | $11.08 | $52.48 | $53.75 | $52.38 |
| Shares | |||||
| Basic Shares Outstanding | 13.4M | 13.4M | 2.6M | 2.6M | 2.6M |
| Diluted Shares Outstanding | 13.4M | 13.4M | 2.6M | 2.6M | 2.6M |
| Profitability Metrics | |||||
| EBITDA | 75.2M | 77.7M | 91.5M | 111.6M | 102.9M |
| D&A | 59.8M | 58.0M | 56.1M | 59.0M | 57.7M |
| EBIT | 15.4M | 19.6M | 35.4M | 52.6M | 45.2M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025